Caregivers at the University of Texas Southwestern Medical Center in Dallas, Texas, have developed a programme designed to facilitate recovery by geriatric patients following hip fracture surgery. The Returning Seniors to Orthopedic Excellence (RESTORE) programme is designed to provide stellar comprehensive collaborative co-managed care for older adults with orthopaedic injuries.
Hologic and the Women's Tennis Association (WTA) kicked off a multi-year partnership, launching a joint vision to achieve greater wellness and equality for women.
Molecular imaging, guided by novel tracers, is emerging as an important diagnostic and therapeutic tool in cardiovascular medicine. Delegates at ICNC-CT, the online International Conference on Nuclear Cardiology and Cardiac CT, also heard that cardiology can learn from fields such as oncology and neurology that have already made important advances in this area. Professor Frank Bengel, who is…
Women are missing out on appropriate cardiac care because guidelines and medications often fail to take into account gender and conditions that specifically affect the female population. Women are also underrepresented in clinical trials for new cardiac therapies.
For the first time, a prospective, international study has shown that chest pain caused by problems with the very small vessels supplying blood to the heart is an important health problem that increases the risk of heart attacks, stroke and death due to cardiovascular reasons. The study, which is published in the European Heart Journal, recruited 686 patients from 14 institutions in seven…
Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses to anti-cancer immunotherapies called PD(L)1 inhibitors, according to preliminary findings to be presented at the 32th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
The increased Covid-19 risk to cardiac patients was discussed during an online presentation at ECR 2020. Focusing on the prevalence of pulmonary embolism in Covid-19 patients, Dr Karl-Friedrich Kreitner, Professor of Radiology at the Department of Diagnostic and Interventional Radiology at the Johannes-Gutenberg University in Mainz, Germany, discussed hypotheses which can explain cardiac…
Heart patients hospitalised with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.(1)
Researchers studying tissue removed from patients noses during surgery believe they may have discovered the reason why so many people with COVID-19 lose their sense of smell, even when they have no other symptoms. In their experiments they found extremely high levels of angiotensin converting enzyme II (ACE-2) only in the area of the nose responsible for smelling. This Enzyme is thought to be the…
The SARS CoV-2 virus which causes COVID-19 may have been named prematurely. As more has become known about the infection, the severe disease does not appear to be a respiratory syndrome at all. Patients who only have a respiratory illness tend not to have a severe condition, while patients who develop a severe condition tend to have non-respiratory conditions, primarily thrombotic or hyper-immune…
Patients with raised blood pressure have a two-fold increased risk of dying from the coronavirus COVID-19 compared to patients without high blood pressure, according to new research published in the European Heart Journal. In addition, the study found that patients with high blood pressure who were not taking medication to control the condition were at even greater risk of dying from COVID-19.
As coronavirus disease COVID-19 continues to jet and alight invisibly around the globe, scientists now report that the virus has mutated to become two strains: the older ‘S-type’ appears milder and less infectious, while the later-emerging ‘L-type’, is more aggressive, spreads more quickly, and currently accounts for about 70 per cent of cases. Worldwide, medical researchers are exploring…
Clinical trial enrolment favours men, according to a study presented at Heart Failure 2018 and the World Congress on Acute Heart Failure, a European Society of Cardiology congress.1 The study found that fewer women meet eligibility criteria for trials of heart failure medication. Helena Norberg, author of the study, junior lecturer and PhD student, Umeå University, Sweden, said: “One of the…
Experts in pediatric kidney disease have published a new staging system to help doctors better predict the length of time until a child with chronic kidney disease (CKD) will need to undergo a kidney transplant or start receiving dialysis. Although this type of prognostic guide exists for adults, this is the first such tool specific to children. “We designed a clinically useful, data-driven…
The recent ACC/AHA Guidelines have increased the number of patients said to have hypertension by up to 40 percent (new 130/80 mmHg). The international recommendation is to treat hypertension with angiotensin converting enzyme inhibitors (ACEIs). These drugs, however, have significant adverse effects: Often a chronic dry cough leads to patients withdrawing from treatment. On rare occasions, ACEIs…
The development of new procedures to monitor cancer treatments is gathering momentum. One such innovation is liquid biopsy. This new lab technique allows non-invasive identification, characterisation and monitoring of circulating tumour DNA. Thus, liquid biopsy can potentially revolutionise oncological diagnostics – and put a spoke in the wheel of radiology. High time to act, says Professor Dr…
A powerful genome editing tool can be deployed as an ace DNA detective, able to sniff out DNA snippets that signal viral infections, cancer, or even defective genes. This genetic detective, developed in the laboratory of Howard Hughes Medical Institute (HHMI) Investigator Jennifer Doudna at the University of California, Berkeley, uses the genome-slicing system known as CRISPR. By combining the…
Newcastle stroke experts are backing a regional campaign launched by Public Health England (PHE). The Act F.A.S.T. stroke campaign launched in the North East urges the public to call 999 if they notice even one of the signs of a stroke in themselves, or in others. Current figures show there are over 64,500 people on GP registers in the North East who have had a stroke, and in 2016 1,765 people…
Standard medical tests miss nearly two-thirds of heart attack diagnoses, reveals research presented at CMR 2018. “Unrecognised MI has a poor short-term prognosis but until now the long-term outlook was unknown,” said lead author Dr Tushar Acharya, a cardiologist at the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, US. “This study investigated long-term…
Exuding the aroma of hi-octane fuel, the glamour of multi-coloured racing leathers, flashy sponsored brands and the glitz of the circuits, motorcycle racing can be an irresistible fast-action sport. Amid the roar of engines, the world’s leading motorcycle aces, such as Marc Marquez, Valentino Rossi or Jonathan Rea, hit around 300kmh on tracks across the globe. High-speed duels thrill the…
The University of Montreal Hospital Research Centre (CRCHUM) is launching a major international clinical trial to test a minimally invasive and safer surgical approach for patients with lung cancer: video-assisted thoracoscopic (VATS) lobectomy with ultrasonic pulmonary artery sealing.
Health always has a political dimension, as seen at two recent international events - the World Health Summit in Geneva in May and the G7 Summit in the Bavarian Alps near Garmisch at the beginning of June. Report: Anja Behringer
The human gut literally teems with microorganisms from at least 1,000 different species that are increasingly considered to be a valuable resource for the prediction, aetiology and prognosis of disease. Due to continual contact with the environment, primarily via food, the gut is susceptible to infection when a virus, parasite or bacterium enters and disrupts normal gut microbiota (or flora).
About 500,000 people in France people suffer heart failure (HF). In Europe the figure is six million and the same in the USA.
Current trends in the medical tourism industry indicate that the needs of international patients are challenging health service providers to come up with advanced solutions for quality healthcare outcomes.
Can an anaesthetist treat a patient with heart failure (HF) without any specialist knowledge of cardiology? That was the question posed by Dr Florian Weis, from the Clinic of Anaesthesiology at the University Hospital of the Ludwig Maximilian University Munich, when lecturing on perioperative management of this patient group.
‘Before each ward round my students and I wash our hands’ – so said Ignaz Philip Semmelweis in the mid-19th century, in his drive to reduce the hospital mortality rate. Today, the World Health Organisation states that ‘Clean care is safer care’ – and yet, particularly in recent times, the lack of hygiene in numerous hospitals has resulted in mortalities. Who is to blame? What can be…
Education and science are not the only exciting aspects of the European Congress of Radiology; the Vienna venue is also a stage on which companies can introduce novel concepts in medical imaging. Following one product’s world premiere during the RSNA 2011 in Chicago, the Echelon Oval 1.5-T MR system is now debuting before a European audience at the ECR 2012.
Prof. Uwe Nixdorff from the European Prevention Centre, Düsseldorf advocates cardiologists combine IMT measurement with ALOKA’s pulse wave intensity function to check for unseen coronary heart disease: “This technique is currently seldom used, however in my experience it provides a more complete picture and enables me to treat patients earlier for life-threatening conditions that are often…
Numerous studies have shown that cocoa has a protective effect against cardiovascular diseases. The reason for this has now been uncovered by researchers at Linköping University in Sweden. When a group of volunteers devoured a good-sized piece of dark chocolate, it inhibited an enzyme in their bodies that is known to raise blood pressure.
The focus on Coronary artery disease – from genes to outcomes at ESC 2010 underlines the importance of CAD diagnosis on the scientific agenda. During the session ‘Multi modality imaging to detect coronary artery disease’, chaired by Professor JJ Bax, of the Cardiology Department at Leiden University Medical Centre, the Netherlands, experts will discuss, for example, the advantages of the…
During its 5th international congress (held in Denmark in April), the European Operating Room Nurses Organisation (EORNA) launched the Accreditation Council for Education (ACE) "Educational and training programmes in the nursing sector need alignment and development on a European level," explained EORNA President Irini Antoniadou. "From 1997 to the present, EORNA achieved a curriculum for a…
Dräger's new Infinity M300 patient-worn monitor has been installed at major hospitals in the USA and Germany. Though compact and patient-worn by adult or paediatric patients, this telemetry system performs like a full-size patient monitor, the manufacturer points out, adding that it runs on a hospital's existing 802.11 b/g network, saving costs on a separate wireless network.
A Canadian study published in the New England Journal of Medicine concludes that chest pain in patients with heart disease could be treated as effective with medication over time as with an expensive angioplasty.
In his lecture Focus on new therapy strategies for heart attacks, Prof. Hans Michael Piper, President of this year's Congress of the German Cardiac Society, gave some fascinating insights in to therapeutic measures after heart attacks.
Ian Mason reports from Chicago
USA - A next-generation radiofrequency ablation catheter - the VNUS ClosureFASTTM - has been used by surgeon Phillip Levin MD, at Cedars-Sinai, in Los Angeles, California. An expert in VNUS closure procedure, Dr Levin has treated approximately 300 patients since 2003 with the ClosureFASTTM catheter's predecessor.
IVAM is an international association of companies and institutes that specialise in microtechnology, nanotechnology and advanced materials.
The results of the blood pressure lowering arm of the ADVANCE (Action in Diabetes and Vascular Disease) study, the largest ever trial conducted in people with type 2 diabetes, were recently reported in the Lancet.
UK & France - The Hypertension in the Very Elderly Trial (HYVET), the biggest global clinical trial to assess the benefits of lowering blood pressure in patients aged 80+, was halted in July, two years before its scheduled completion in 2009.
The interest in using traditional Chinese medicine (TCM) alongside conventional Western medical care has steadily increased among European physicians; it is no longer unusual, for example, for acupuncture to be suggested by a doctor to help fight tobacco addiction, or to ease a persistent musculoskeletal problem.
Once upon a time iSOFT was the software 'wunderkind', with sales hitting the billion-euro mark. Then disaster struck. Money and reputation vanished. But that was once upon a time today iSOFT is back - with fresh strategies aimed at a happy ending. Daniela Zimmermann, of European Hospital, met with Peter Herrmann (above), Managing Director of iSOFT Deutschland, to discuss old mistakes and new…
Congestive heart failure (CHF) is a major healthcare problem with 1-2% of the population affected in Western countries. Because it increases with age, the prevalence of CHF is escalating with our aged populations.
25,000 visitors and medical professionals from 47 National Cardiac Societies across central and greater Europe, will attend the 2004 ESC Congress, where 'Diabetes and heart disease' will be the main theme. Lars Ryden, ESC Past-President, team member for the Euro-Heart Survey on Diabetes, and Chairman of the 'Guidelines for Diabetes & the Heart', and William Wijns, co-chair and Chairman of the…
The DynaWell L-Spine, a compression harness that axially loads the lumbar spine in the supine position, has no magnetic parts, so can be used with most CT and MRI scanners.